Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

GLUT1 rs1385129G>A Raised the Risk and Poor Prognosis of Lung Cancer: A Case-Control Study.

Human mutation - 1 Jan 2026

Li Zhi, Wang Dedong, Chen Jinbin, Wu Di, Tang Shuyu, Huang Jinyi, Deng Yibin, Wang Xinhua, Qiu Fuman, Yang Lei, Lu Jiachun

Abstract excerpt

Background: Energy metabolism reprogramming of cancer cells with the abnormal glycolytic capacity represents a novel direction of tumor therapy. Nevertheless, there is a lack of evidence linking genetic variations in glycolysis-related genes to the risk and clinical progression of lung cancer (LC). This study is aimed at clarifying the genetic effect of glycolytic pathway-related genes on the occurrence and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Alleles
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Association Studies

Share to Glucose Transporter Type 1

Share to Lung Neoplasms

Share to Prognosis

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 42094236
DOI: 10.1155/humu/9935937
PMCID: PMC13139712

Genes

ENO2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

GLUT1 rs1385129G>A Raised the Risk and Poor Prognosis of Lung Cancer: A Case-Control Study.PMID 42094236Read ↗

Prognosis and Immunological Characteristics of PGK1 in Lung Adenocarcinoma: A Systematic AnalysisSemantic proximity Read ↗

Identification of four metabolic subtypes and key prognostic markers in lung adenocarcinoma based on glycolytic and glutaminolytic pathwaysSemantic proximity Read ↗

Identification of a glycolysis‐related gene signature associated with clinical outcome for patients with lung squamous cell carcinomaSemantic proximity Read ↗

Predicting the difference in treatment response and survival time of lung adenocarcinoma patients based on a prognostic risk model of glycolysis-related genesSemantic proximity Read ↗

AL355338 acts as an oncogenic lncRNA by interacting with protein ENO1 to regulate EGFR/AKT pathway in NSCLCSemantic proximity Read ↗

Comprehensive analyses of metabolism-related lncRNA for LUADSemantic proximity Read ↗

Identification of a 5-Gene Metabolic Signature for Predicting Prognosis Based on an Integrated Analysis of Tumor Microenvironment in Lung AdenocarcinomaSemantic proximity Read ↗

Development and validation of a metabolic gene signature for predicting the overall survival of patients in lung adenocarcinoma with lymph node metastasisSemantic proximity Read ↗

Development and validation of glycolysis-cholesterol synthesis genes in lung adenocarcinomaSemantic proximity Read ↗

Comprehensive Analysis of Alteration Landscape and Its Clinical Significance of Mitochondrial Energy Metabolism Pathway‐Related Genes in Lung CancersSemantic proximity Read ↗

Glycolysis Changes the Microenvironment and Therapeutic Response Under the Driver of Gene Mutation in Esophageal AdenocarcinomaSemantic proximity Read ↗

Identification of subgroups and development of prognostic risk models along the glycolysis-cholesterol synthesis axis in lung adenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.